GTPaseアクティベーターであるDOCK4は,腫瘍発生時に破壊される
Vijay Yajnik1, Charles Paulding, Raffaella Sordella
1Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
Cell
|March 12, 2003
まとめ
マウスモデルでのゲノム切除は,細胞の結合を調節する遺伝子であるDOCK4が,腫瘍の進行中に破壊されていることを明らかにしています. 変異したDOCK4は細胞結合を弱め,癌の成長を促し,腫瘍発生におけるその役割を強調しています.
科学分野:
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
- がん研究 がん研究
背景:
- 腫瘍発生は,がんの進行を促すゲノム削除を含む遺伝的変化を含みます.
- CDM遺伝子ファミリーは,細胞プロセスに不可欠な小さなGTPasesのレギュレータをコードします.
- CDMファミリーのメンバーであるDOCK4は,細胞粘着とGTPaseの活性を調節することに関与しています.
研究 の 目的:
- マウスモデルでの腫瘍進行中に選択されたゲノム欠損を特定するために.
- 腫瘍形成と細胞結合形成におけるDOCK4遺伝子の役割を調査する.
主な方法:
- 代表的差異分析は,マウス腫瘍モデルにおける同同同位体のゲノム欠損を特定するために使用されました.
- DOCK4の活性を評価するために,細胞系とインビボモデルにおける機能的測定を用いた.
- DOCK4の機能を評価するために,C. elegansにおける補充試験を実施した.
主要な成果:
- マウスモデルでの腫瘍進行中にDOCK4を標的とした同同位体のデリレーションが特定されました.
- DOCK4はRap GTPaseを活性化させ,アデレンス結合の形成を強化する.
- ヒトの癌に見られる変異DOCK4は,Rap1の活性化に欠陥があり,モデル生物の細胞欠陥を救済することができない.
- 野生型のDOCK4の発現は,マウスのがん細胞のアンカージ・インデペンデントな成長と侵入を抑制する.
結論:
- DOCK4は細胞間結合の重要な調節体であり,腫瘍抑制剤である.
- ゲノム欠損や変異によるDOCK4の破壊は,がんの発症に寄与する.
- 細胞結合におけるDOCK4の機能と,がんにおけるDOCK4の無活性化は,DOCK4の治療的重要性を強調している.
関連する概念動画
GTPases and their Regulation
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Large G-proteins, also known...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
GTPases and their Regulation
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Large G-proteins, also known...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:


